Barclays’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-226,433
| Closed | -$1.43M | – | 4565 |
|
|
2022
Q4 | $1.43M | Hold |
226,433
| – | – | ﹤0.01% | 1855 |
|
|
2022
Q3 | $1.16M | Buy |
226,433
+109,375
| +93% | +$560K | ﹤0.01% | 2028 |
|
|
2022
Q2 | $733K | Buy |
117,058
+41,868
| +56% | +$262K | ﹤0.01% | 2292 |
|
|
2022
Q1 | $267K | Buy |
+75,190
| New | +$267K | ﹤0.01% | 3151 |
|
|
2019
Q3 | – | Sell |
-4,539
| Closed | -$67K | – | 4528 |
|
|
2019
Q2 | $67K | Buy |
4,539
+3,560
| +364% | +$52.5K | ﹤0.01% | 3751 |
|
|
2019
Q1 | $41K | Buy |
979
+954
| +3,816% | +$40K | ﹤0.01% | 3729 |
|
|
2018
Q4 | $1K | Sell |
25
-1,289
| -98% | -$51.6K | ﹤0.01% | 4044 |
|
|
2018
Q3 | $63K | Buy |
1,314
+1,087
| +479% | +$52.1K | ﹤0.01% | 3646 |
|
|
2018
Q2 | $10K | Sell |
227
-148
| -39% | -$6.52K | ﹤0.01% | 3907 |
|
|
2018
Q1 | $23K | Sell |
375
-1,025
| -73% | -$62.9K | ﹤0.01% | 3807 |
|
|
2017
Q4 | $75K | Buy |
+1,400
| New | +$75K | ﹤0.01% | 3151 |
|